The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nikolaeva E.A.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Barkovskaya M.K.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Valieva Z.S.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Shariya A.M.

Chazov National Medical Research Center of Cardiology, Moscow, Russia

Martynyuk t.V.

Chazov National Medical Research Center of Cardiology, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Assessing the quality of life with various questionnaires in newly diagnosed precapillary pulmonary hypertension

Authors:

Nikolaeva E.A., Barkovskaya M.K., Valieva Z.S., Shariya A.M., Martynyuk t.V.

More about the authors

Journal: Russian Cardiology Bulletin. 2026;21(1): 41‑48

Read: 590 times


To cite this article:

Nikolaeva EA, Barkovskaya MK, Valieva ZS, Shariya AM, Martynyuk tV. Assessing the quality of life with various questionnaires in newly diagnosed precapillary pulmonary hypertension. Russian Cardiology Bulletin. 2026;21(1):41‑48. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20262101141

Recommended articles:

References:

  1. https://doi.org/10.15829/1560-4071-2024-6161 
  2. Chazova IE, Martynyuk TV, Shmalts AA, Gramovich VV, Danilov NM, Veselova TN, Korobkova IZ, Sarybaev ASh, Stukalova OV, Azizov VA, Barbarash OL, Galyavich AS, Gorbachevsky SV, Medvedeva EA, Matchin YuG, Mukarov MA, Nakonechnikov SN, Filippov EV, Chernogrivov IE. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023). Eurasian heart journal. 2024;(1):6-85. (In Russ.). https://doi.org/10.38109/2225-1685-2024-1-6-85
  3. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct 11;43(38):3618-3731. https://doi.org/10.1093/eurheartj/ehac237
  4. Nikolaeva EA, Martynyuk TV. New criteria for diagnosis of pulmonary arterial hypertension: pros and cons. Systemic Hypertension. 2023;20(2):21-27. (In Russ.). https://doi.org/10.38109/2075-082X-2023-2-21-27
  5. Nikolaeva EA, Valieva ZS, Martynyuk TV. Quality of life assessment in patients with pulmonary arterial hypertension. Systemic Hypertension. 2024;21(3):41-46. (In Russ.). https://doi.org/10.38109/2075-082X-2024-3-41-46
  6. Lyapina I.N., Valieva Z.S., Martynyuk T.V. Specific Therapy Strategy Choice for Patients With Pulmonary Arterial Hypertension and Inoperable Chronic Thromboembolic Pulmonary Hypertension: Switch or Escalate. Kardiologiia. 2025;65(1):50-57. (In Russ.). https://doi.org/10.18087/cardio.2025.1.n2844
  7. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине (4-е издание, переработанное и дополненное) / Под ред. ак. РАН Ю.Л. Шевченко. М.: Изд-во Национального медико-хирургического Центра им. Н.И. Пирогова, 2021.
  8. https://doi.org/10.30809/phe.1.2018.1 
  9. Instructions for processing data obtained with the SF-36 questionnaire. (In Russ.). https://bono-esse.ru/blizzard/RPP/sf36.pdf
  10. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208.  https://doi.org/10.1016/0168-8510(90)90421-9
  11. Amirdjanova VN, Erdes ShF. Validation of the Russian version of the general questionnaire EuroQol-5D (EQ-5D). Scientific and practical rheumatology. 2007;45(3):69-76.  https://doi.org/10.14412/1995-4484-2007-691
  12. McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006 Feb;15(1):103-15.  https://doi.org/10.1007/s11136-005-3513-4
  13. McCollister D, Shaffer S, Badesch DB, Filusch A, Hunsche E, Schüler R, Wiklund I, Peacock A; IRB information for the 5 clinical sites. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH. Respir Res. 2016 Jun 14;17(1):72.  https://doi.org/10.1186/s12931-016-0388-6
  14. Yorke J, Corris P, Gaine S, Gibbs JS, Kiely DG, Harries C, Pollock V, Armstrong I. emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J. 2014 Apr;43(4):1106-13.  https://doi.org/10.1183/09031936.00127113
  15. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004 Nov;126(5):1452-9.  https://doi.org/10.1378/chest.126.5.1452
  16. Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, Gallop R, Christie J, Hansen-Flaschen J, Palevsky H. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005 Aug 10;6(1):92.  https://doi.org/10.1186/1465-9921-6-92
  17. White J, Hopkins RO, Glissmeyer EW, Kitterman N, Elliott CG. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 2006 Mar 31;7(1):55.  https://doi.org/10.1186/1465-9921-7-55
  18. Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. Chest. 2017 Jan;151(1):106-118.  https://doi.org/10.1016/j.chest.2016.08.1473
  19. Shostak N.A., Klimenko A.N., Shemenkova V.S., Svet A.V. Use of the SF-36 questionnare in assessment of quality of life in patients with chronic thromboembolic pulmonary hypertension. The Clinician. 2017;11(3-4):44-49. (In Russ.). https://doi.org/10.17650/1818-8338-2017-11-3-4-44-49
  20. Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002 Aug 1;347(5):322-9.  https://doi.org/10.1056/NEJMoa020204
  21. Jaïs X, D’Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin LJ; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34.  https://doi.org/10.1016/j.jacc.2008.08.059
  22. Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013 Jul 25;369(4):330-40.  https://doi.org/10.1056/NEJMoa1209655
  23. Reis A, Santos M, Vicente M, Furtado I, Cruz C, Melo A, Carvalho L, Gonçalves F, Sa-Couto P, Almeida L. Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study. Biomed Res Int. 2018 Mar 19;2018:3924517. https://doi.org/10.1155/2018/3924517
  24. Newnham M, Bunclark K, Abraham N, Ali S, Amaral-Almeida L, Cannon JE, Doughty N, Ng C, Ponnaberanam A, Sheares K, Speed N, Taboada D, Toshner M, Tsui S, Jenkins DP, Pepke-Zaba J. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2020 Oct 1;56(4):1902096. https://doi.org/10.1183/13993003.02096-2019
  25. Lewis RA, Armstrong I, Bergbaum C, Brewis MJ, Cannon J, Charalampopoulos A, Church AC, Coghlan JG, Davies RJ, Dimopoulos K, Elliot C, Gibbs JSR, Gin-Sing W, Haji G, Hameed AG, Howard LS, Johnson MK, Kempny A, Kiely DG, Lo Giudice F, McCabe C, Peacock AJ, Peleyeju O, Pepke-Zaba J, Polwarth G, Price L, Sabroe I, Schreiber BE, Sheares K, Taboada D, Thompson AAR, Toshner MR, Wanjiku I, Wort SJ, Yorke J, Condliffe R. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study. Eur Respir J. 2021 Feb 25;57(2):2000124. https://doi.org/10.1183/13993003.00124-2020
  26. Chin KM, Gomberg-Maitland M, Channick RN, Cuttica MJ, Fischer A, Frantz RP, Hunsche E, Kleinman L, McConnell JW, McLaughlin VV, Miller CE, Zamanian RT, Zastrow MS, Badesch DB. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial. Chest. 2018 Oct;154(4):848-861.  https://doi.org/10.1016/j.chest.2018.04.027

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.